Vancouver, British Columbia, Canada, April 26, 2022 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced CEO Brad Moore has been invited to deliver a keynote speech at Cannabis Business Europe in Frankfurt, Germany, June 14 at 9:45 am. Brad will also join a Q&A Roundtable with event speakers later that day.
In his speech “Dosing: Where Does the Responsibility Lie?” Brad will highlight the challenges cannabis cultivators face in measuring a plant and the lack of available data. He will present GCAC’s cultivator-to-consumer solution to over 400 industry professionals.
“Consistently growing cannabis is hard. The slightest input can dramatically change the desired outcome, resulting in a loss of sales and brand reputation. Data recording and tracking of the plant’s lifecycle is lacking. GCAC’s Efixii is the world’s first patent-pending blockchain solution for the cannabis industry,” says CEO Brad Moore.
The Efixii blockchain solution records every step in the cannabis plant lifecycle from seed to the consumer and back. Data on a blockchain remains forever, it cannot be altered, and everyone can view it. There are quantifiable benefits for every supply chain segment, including consumers.
Moore adds, “Our SeedtoSeedTM real-time feedback loop cements a relationship from cultivator to consumer and back, including every stakeholder. Scanning a secure Efixii QR code shows each step for improved data and transparency. The free-to-use consumer app lets you read and submit genuine product reviews measuring ‘one gram grown, one gram consumed.’ Enriched product knowledge for better outcomes.”
The information is fed back through the entire system, allowing cultivators, manufacturers and retailers to understand what worked and why. They can review each detail to develop repeatable processes and consistent cannabis. Manufacturers and retailers also benefit from Efixii data to streamline supply chain efficiencies and source the best product.
Efixii is licensed to cultivators in a SaaS model and is a free-to-use app for cannabis consumers. All cannabis sold through the Portal generates a new sales-commission revenue stream for GCAC. Efixii’s cannabis data is the intellectual property (“IP”) of GCAC. This IP creates an inherent difficulty in replicating or competing with GCAC’s cannabis datasets. GCAC defined their protocols in a provisional U.S. patent application, ‘System of Process and Tracking Cannabis Products and Associated Method Using Blockchain’ filed with the USPTO on Dec. 17, 2020.
GCAC is a global leader in designing, developing, SaaS licensing and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world's first end-to-end - from patient to regulator - medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from SaaS licensing its technology and acquiring high-quality cannabis datasets that improve patient outcomes and become the world’s largest cannabis efficacy data provider.
This news release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.